Molecular control of the amount, subcellular location, and activity state of translation elongation factor 2 in neurons experiencing stress.

[1]  M. Cano,et al.  In vitro and in vivo protection by melatonin against the decline of elongation factor‐2 caused by lipid peroxidation: preservation of protein synthesis , 2012, Journal of pineal research.

[2]  M. Mattson,et al.  Recruiting adaptive cellular stress responses for successful brain ageing , 2012, Nature Reviews Neuroscience.

[3]  W. Sossin,et al.  Compartment‐specific, differential regulation of eukaryotic elongation factor 2 and its kinase within Aplysia sensory neurons , 2011, Journal of neurochemistry.

[4]  G. Kaul,et al.  Eukaryotic elongation factor‐2 (eEF2): its regulation and peptide chain elongation , 2011, Cell biochemistry and function.

[5]  D. T. Kurtz,et al.  The role of protein synthesis in cell cycling and cancer , 2009, Molecular oncology.

[6]  A. Hinnebusch,et al.  Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets , 2009, Cell.

[7]  S. Leppla,et al.  The diphthamide modification on elongation factor‐2 renders mammalian cells resistant to ricin , 2008, Cellular microbiology.

[8]  A. Ryazanov,et al.  A pharmacoproteomic approach implicates eukaryotic elongation factor 2 kinase in ER stress-induced cell death , 2008, Cell Death and Differentiation.

[9]  B. Halliwell,et al.  Deciphering the mechanism of HNE-induced apoptosis in cultured murine cortical neurons: Transcriptional responses and cellular pathways , 2007, Neuropharmacology.

[10]  G. Scheper,et al.  Translation matters: protein synthesis defects in inherited disease , 2007, Nature Reviews Genetics.

[11]  D. Trono,et al.  Production and Titration of Lentiviral Vectors , 2006, Current protocols in neuroscience.

[12]  Julian N. Selley,et al.  Global Translational Responses to Oxidative Stress Impact upon Multiple Levels of Protein Synthesis* , 2006, Journal of Biological Chemistry.

[13]  John H. Zhang,et al.  Neurovascular and neuronal protection by E64d after focal cerebral ischemia in rats , 2006, Journal of neuroscience research.

[14]  M. Bektaş,et al.  Endogenous ADP‐ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions , 2006, Cell biochemistry and function.

[15]  D. Kaplan,et al.  The p53 family in nervous system development and disease , 2006, Journal of neurochemistry.

[16]  R. Zhao,et al.  Suppressive effect of elongation factor 2 on apoptosis induced by HIV-1 viral protein R , 2006, Apoptosis.

[17]  A. R. Merrill,et al.  The life and death of translation elongation factor 2. , 2006, Biochemical Society transactions.

[18]  N. Sonenberg,et al.  Translational control in stress and apoptosis , 2005, Nature Reviews Molecular Cell Biology.

[19]  M. Hentze,et al.  Molecular mechanisms of translational control , 2004, Nature Reviews Molecular Cell Biology.

[20]  D. Campbell,et al.  14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. , 2004, The Biochemical journal.

[21]  Mark P Mattson,et al.  Metal‐Catalyzed Disruption of Membrane Protein and Lipid Signaling in the Pathogenesis of Neurodegenerative Disorders , 2004, Annals of the New York Academy of Sciences.

[22]  B. Fontoura,et al.  Cytoplasmic complex of p53 and eEF2 , 2003, Journal of cellular physiology.

[23]  E. Barrett,et al.  Human protein metabolism: its measurement and regulation. , 2002, American journal of physiology. Endocrinology and metabolism.

[24]  C. Proud,et al.  Regulation of peptide-chain elongation in mammalian cells. , 2002, European journal of biochemistry.

[25]  C. Proud,et al.  Regulation of mammalian translation factors by nutrients. , 2002, European journal of biochemistry.

[26]  C. Proud,et al.  Cellular stresses profoundly inhibit protein synthesis and modulate the states of phosphorylation of multiple translation factors. , 2002, European journal of biochemistry.

[27]  A. Castaño,et al.  Effects of aging on the various steps of protein synthesis: fragmentation of elongation factor 2. , 1999, Free radical biology & medicine.

[28]  K. Kinzler,et al.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.

[29]  M. Bektaş,et al.  Interactions of elongation factor 2 with the cytoskeleton and interference with DNase I binding to actin. , 1998, European journal of biochemistry.

[30]  D. Absher,et al.  FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. , 1997, Molecular cell.

[31]  M. Mattson,et al.  Evidence that 4-Hydroxynonenal Mediates Oxidative Stress-Induced Neuronal Apoptosis , 1997, The Journal of Neuroscience.

[32]  M. Mattson,et al.  Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[33]  Zhen Y. Jiang,et al.  Lipid hydroperoxide measurement by oxidation of Fe2+ in the presence of xylenol orange. Comparison with the TBA assay and an iodometric method , 1991, Lipids.

[34]  S. Kater,et al.  Roles for mitotic history in the generation and degeneration of hippocampal neuroarchitecture , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  A. Ryazanov,et al.  Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation , 1988, Nature.

[36]  C. S. Parker,et al.  A Drosophila RNA polymerase II transcription factor contains a promoter-region-specific DNA-binding activity , 1984, Cell.